4 Einträge gefunden

1. First-line treatment of unresectable or metastatic HER2 positive esophagogastric adenocarcinoma: liquid biomarker analysis of the phase 2 INTEGA trial

   1. Paschold, Lisa
   2. Stein, Alexander
   3. Thiele, Benjamin
   4. Tintelnot, Joseph
   5. Henkes, Svenja-Sibylla
   6. Coith, Cornelia
   7. Schultheiß, Christoph

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Efficacy of Ipilimumab vs FOLFOX in Combination With Nivolumab and Trastuzumab in Patients With Previously Untreated ERBB2-Positive Esophagogastric Adenocarcinoma: The AIO INTEGA Randomized Clinical Trial

   1. Stein, Alexander
   2. Paschold, Lisa
   3. Tintelnot, Joseph
   4. Goekkurt, Eray
   5. Henkes, Svenja-Sibylla
   6. Simnica, Donjete
   7. Schultheiss, Christoph

   2022 - Forschungsinformationssystem des UKE
3. Translational analysis and final efficacy of the AVETUX trial - Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer

   1. Tintelnot, Joseph
   2. Ristow, Inka
   3. Sauer, Markus
   4. Simnica, Donjete
   5. Schultheiß, Christoph
   6. Scholz, Rebekka
   7. Goekkurt, Eray

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer

   1. Stein, Alexander
   2. Simnica, Donjete
   3. Schultheiß, Christoph
   4. Scholz, Rebekka
   5. Tintelnot, Joseph
   6. Gökkurt, Eray
   7. von Wenserski, Lisa

   2021 - Forschungsinformationssystem des UKE - frei zugänglich